Pharmacy Times 2008 OTC Products - (Page 2) M AC IS T RE C O M M N EN • PH AR ® DED • 8 Ac h ie v em e n t Aw M M AC IS T RE C O 12 Years Strong M ar SINCE 1997 PH AR PH AR d • PH AR 20 d 0 M AC IS T RE C O M M M AC IS T R E C O M M EN N EN EN harmacy Times has been tabulating pharma- proud to announce that the Survey of Pharmacists cists’ recommendations and publishing its Recommendations has greatly expanded over the SINCE Survey of Pharmacists Recommendations past 12 years and, this year, we surveyed a total 8 8 w w 19 7 Ac for 12 years. Pharmacy Times began collecting data of A142 categories. The survey9has expanded from A ch i h ie v tA e v em e n t A in 1997 regarding whichem e n brands pharmacists the traditional OTC categories, such as Cough and OTC a ch w ie ve recommended most frequently and how many Cold and Analgesics, to include new A t subcategories, men recommendations pharmacists made per month— new products, and products that have switched from Rx to OTC status. As the OTC market has invaluable data for the OTC marketplace. Why are these CIST RE Cvaluable? Pharmacists grown, Pharmacy Times has responded accordingly data so O M ST RE C O M M A CI M make more than 80 million recommendations to Aby adding new therapeutic areas to the survey. The their patients T R EC O M every month, and more often than past decade saw several “blockbuster” drugs switch S M CI status—some examnot, patients will follow these recommendations. from prescription to OTC R T EC OM C IS In the Cough and Cold category alone, includ- ples include Zyrtec, Pepcid, Prilosec, and Claritin, A M ing adult and pediatric formulations, pharmacists which are all now available, in some form, over the 8 make more thanA 15 million w recommendations 8 counter. As new categories develop and the OTC A ch w Ac every month. As thei e v em e accessible health care marketplaceAcontinues to evolve, Pharmacy Times most n t hi SINCEplay a key role in patients’ wille v em e n t concurrently expand its Survey of Pharmacist provider, pharmacists 1997 health and have the opportunity to recommend Recommendations. 08 tA A Thank you to the many pharmacists who conOTC productsctoi their patients on a daily basis. h e ve m e n A a Initially, we surveyed pharmacists’ recommenda- tributed their input cto the successful outcome of w h ie ve m e n t A tions in a total of 85 therapeutic categories; we are this survey. P DED DED D ED • ar ar M PH AR M PH AR • PHARM A d PHA R d ar rd ar w rd PHA ar d R 20 20 d 2 00 0 0 8 EN EN DED DED N EN DE M 20 D• 20 EN M A 0 0 D ED A CI ST PHARM R EC O M A R PHARM PHA d ar d 08 08 ar Ac Ac h i e ve m e n tA tA h i e ve m e n A a ch w ie ve tA men T R EC O M rd w PHA w R S CI M E MA OTC Supplement 2008 20 CI ST R EC O M AC 2 00 8 2 00 A 8 ch M EN EN EN M M IS T R E C O DE M M EN M N EN DE D AC IS T R E D ED D 20 2 00 20 T R EC O M 2 CI 8 S 2 00 A 8 ch ie ve men M EN Pharmacy Times DE
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.